IP Library Granted Patent US 7,563,462
Granted Patent B2
US 7,563,462 · App. 11/452,246 · Granted Jul 21, 2009

Methods for modulating eicosanoid metabolism

Assignees: The University of Texas MD Anderson Cancer Center; New Chapter Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,563,462
App. No.
11/452,246
Granted
Jul 21, 2009
Kind
B2
Abstract

The inventive subject matter relates to methods for modulating an eicosanoid metabolic process in cells of an animal in need thereof, which comprises administering to the animal an amount of the inventive compositions effective for regulating the activity of an eicosanoid oxygenase. In particular, the inventive subject matter relates to methods for modulating arachadonic acid metabolism by administering an amount of the inventive compositions effective for regulating the activity of lipoxygenases and cyclooxygenases.

Claims (22)

1. A method for modulating an eicosanoid metabolic process in cells of an animal in need thereof, which comprises administering to the animal an amount of a composition effective for regulating the activity of an eicosanoid oxygenase,

wherein the composition comprises therapeutically effective amounts of supercritical extracts of rosemary, turmeric, oregano and ginger; and therapeutically effective amounts of hydroalcoholic extracts of holy basil, ginger, turmeric, Scutellaria baicalensis , rosemary, green tea, huzhang, Chinese goldthread, and barberry.

2. The method of claim 1 , wherein the cells are cancer cells.

3. The method of claim 2 , wherein the cancer cells comprise prostate cancer cells, breast cancer cells, lung cancer cells, colon cancer cells, or a combination thereof.

4. The method of claim 2 , wherein the eicosanoid metabolic process is aberrant metabolism associated with cellular transformation to cancer, cancer cell proliferation, cancer cell metastasis, cancer cell invasiveness, cancer cell-modulated angiogenesis, cancer cell-modulated apoptosis suppression, or a combination thereof.

5. The method of claim 2 , wherein the eicosanoid is selected from the group consisting of arachidonic acid and linolinic acid.

6. The method of claim 5 , wherein the eicosanoid is arachidonic acid.

7. The method of claim 1 , wherein the eicosanoid oxygenase is cyclooxygenase-1, cyclooxygenase-2, 5-lipoxygenase, 12-lipoxygenase, or a combination thereof.

8. The method of claim 7 , wherein the eicosanoid oxygenase is 12-lipoxygenase.

9. The method of claim 7 , wherein the eicosanoid oxygenase is 5-lipoxygenase.

10. The method of claim 7 , wherein the eicosanoid oxygenase is cyclooxygenase-1, cyclooxygenase-2, or a combination thereof.

11. The method of claim 10 , wherein the eicosanoid oxygenase is cyclooxygenase-1.

12. The method of claim 10 , wherein the eicosanoid oxygenase is cyclooxygenase-2.

13. The method of claim 1 , wherein the regulation of the activity of an eicosanoid oxygenase is inhibition.

14. The method of claim 1 , wherein modulation of an eicosanoid metabolic process comprises inhibiting NF-κB activity in the cells of the animal.

15. The method of claim 1 , wherein the animal is human.

16. A method of delivering 13-S-HODE to an animal in need thereof, comprising administering to the animal a composition comprising therapeutically effective amounts of supercritical extracts of rosemary, turmeric, oregano and ginger; and therapeutically effective amounts of hydroalcoholic extracts of holy basil, ginger, turmeric, Scutellaria baicalensis , rosemary, green tea, huzhang, Chinese goldthread, and barberry.

17. The method of claim 16 , wherein the animal is human.

18. A method for inhibiting arachidonic acid-mediated inflammation in an animal in need thereof, comprising administering to the animal a composition comprising therapeutically effective amounts of supercritical extracts of rosemary, turmeric, oregano and ginger; and therapeutically effective amounts of hydroalcoholic extracts of holy basil, ginger, turmeric, Scutellaria baicalensis , rosemary, green tea, huzhang, Chinese goldthread, and barberry.

19. The method of claim 18 , wherein the animal is human.

20. A method for modulating the level of NF-κB-regulated gene products in cells of an animal in need thereof, comprising administering to the animal a composition comprising therapeutically effective amounts of supercritical extracts of rosemary, turmeric, oregano and ginger; and therapeutically effective amounts of hydroalcoholic extracts of holy basil, ginger, turmeric, Scutellaria baicalensis , rosemary, green tea, huzhang, Chinese goldthread, and barberry.

21. The method of claim 20 , wherein the animal is human.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Oct 11, 2012
From: BROWN BROTHERS HARRIMAN & CO. (AS ADMINISTRATIVE AGENT)
To: NEW CHAPTER, INC.; NEW CHARTER DISTRIBUTION, INC.; NATURE'S INSIGHT, INC.
Reel/Frame 029110/0220 →
CORRECTIVE ASSIGNMENT TO CORRECT ASSIGNEE NAME TO BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM AND TO CORRECT ASSIGNEE ADDRESS TO 201 W. 7TH ST. AUSTIN TEXAS 78701 PREVIOUSLY RECORDED ON REEL 018561 FRAME 0929. Recorded Apr 29, 2010
From: NEWMAN, ROBERT; AGGARWAL, BHARAT
To: BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 024314/0265 →
SECURITY AGREEMENT Recorded Jun 2, 2009
From: NEW CHAPTER, INC.; NEW CHARTER DISTRIBUTION, INC.; NATURE'S INSIGHT, INC.
To: BROWN BROTHERS HARRIMAN & CO., AS ADMINISTRATIVE AGENT
Reel/Frame 022764/0705 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 21, 2006
From: NEWMARK, THOMAS; SCHULICK, PAUL
To: NEW CHAPTER INC.
Reel/Frame 018546/0234 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 21, 2006
From: NEWMAN, ROBERT; AGGARWAL, BHARAT
To: THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER
Reel/Frame 018561/0929 →
Continuity (3)
Provisional Application 6069016100 · Jun 14, 2005
Provisional Application 6079233000 · Apr 17, 2006
Related Publication 20070042059A1 · Feb 22, 2007